Current treatment status-Undergoing active treatment - Page 12 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment Posts on Medivizor

Should ALL patients undergoing induction therapy be screened for virus infection?

Should ALL patients undergoing induction therapy be screened for virus infection?

Posted by on Oct 17, 2017 in Leukemia | 0 comments

In a nutshell This study examined the benefit of virus surveillance in patients undergoing induction therapy for acute lymphoblastic leukemia (ALL). This study concluded that many patients were at high risk for virus infection and screening during induction therapy could be helpful. Some background Leukemia patients who are undergoing stem cell...

Read More

Treatment with PD-1 agents improves melanoma outcomes

Treatment with PD-1 agents improves melanoma outcomes

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell This review investigated the effectiveness of PD-1 agents in the treatment of melanoma. Researchers suggested that treatment with these agents is associated with improved cancer outcomes.   Some background The best treatment for melanoma remains to be determined, however surgery may be associated with a high cure rate. Patients...

Read More

A 2017 update on CLL management

A 2017 update on CLL management

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study reviewed recent evidence on the management of chronic lymphocytic leukemia (CLL). Some background CLL is cancer of the blood and bone marrow. It is one of the most common types of leukemia in adults. The average age at diagnosis ranges from 67 to 72 years. Standard therapy for CLL usually involves a combination of...

Read More

Reducing the dosage of dasatinib does not prevent a second occurrence of fluid build-up in the lungs

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study examined a side effect called pleural effusion (PE; fluid build-up in the lungs) in patients with chronic myeloid leukemia (CML) treated with dasatinib (Sprycel). PE occurred in 23% of patients. This study concluded that reducing the dose of dasatinib after the first occurrence of PE did not prevent a recurrence.  Some...

Read More

Is hyperthyroidism a consequence of hematopoietic stem cell transplant for acute myeloid leukemia patients?

Is hyperthyroidism a consequence of hematopoietic stem cell transplant for acute myeloid leukemia patients?

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the thyroid function in acute myeloid leukemia (AML) patients who were treated with allogeneic hematopoietic stem cell transplant (allo-HSCT). This study concluded that a significant number of AML patients treated with allo-HSCT experience hyperthyroidism.  Some background An allogeneic...

Read More

Using erythropoietin mouthwash to reduce the occurrence of oral mucositis in patients receiving autologous stem cell transplantation

Using erythropoietin mouthwash to reduce the occurrence of oral mucositis in patients receiving autologous stem cell transplantation

Posted by on Oct 7, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at how effective erythropoietin mouthwash was at preventing oral mucositis in cancer patients being treated with autologous stem cell transplantation. The study concluded that rinsing with erythropoietin mouthwash can prevent oral mucositis.  Some background Oral mucositis (OM) is a complication associated with...

Read More

Adult vs pediatric regimens for treating adolescents and young adults with Hodgkin lymphoma

Adult vs pediatric regimens for treating adolescents and young adults with Hodgkin lymphoma

Posted by on Oct 5, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared adult and pediatric treatment regimens for adolescent and young adult patients with Hodgkin lymphoma. The study concluded that adolescent and young adult patients treated with the pediatric regimen have better outcomes than those treated with the adult regimen.  Some background Hodgkin lymphoma (HL) is one of...

Read More

10-years on: Imatinib as a first-line therapy for CML

10-years on: Imatinib as a first-line therapy for CML

Posted by on Oct 3, 2017 in Leukemia | 0 comments

In a nutshell This study examined treatment combinations involving imatinib (Gleevec) for chronic myeloid leukemia (CML). Researchers concluded that treatment with standard-dose imatinib achieved a survival comparable to that of the general population. Patient disease factors affected outcomes more than initial treatment selection. Some background...

Read More

Managing high-risk multiple myeloma

Posted by on Oct 2, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study reviewed evidence on the management of high-risk multiple myeloma.  Some background Multiple myeloma is a diverse disease. Using predictors of treatment success is important to help select treatment approaches for patients. Higher risk patients may benefit from more aggressive treatment. There are multiple methods...

Read More

A treatment for fatigue in breast cancer patients who are undergoing chemotherapy

A treatment for fatigue in breast cancer patients who are undergoing chemotherapy

Posted by on Sep 30, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the effect of therapeutic care for fatigue in breast cancer patients who are undergoing chemotherapy. This study concluded that therapeutic care may decrease fatigue in breast cancer patients undergoing chemotherapy.  Some background The standard of care treatment option for breast cancer and...

Read More

The Benefits of Exercise During CLL Treatment

Posted by on Sep 28, 2017 in Leukemia | 0 comments

Video information: What are the benefits of exercise for CLL patients—even during treatment?  Andrew Schorr, Patient Power founder, poses this question to an expert panel, including Dr. Michael Keating, Dr. Wenli Liu and Dr. Nicole Lamanna. The panelists discuss the positive benefits of exercise on the mind and body and the importance of...

Read More